Salvato in:
Dettagli Bibliografici
Autori principali: Zhan, Shuai, Zhang, Ningjing, Lou, Yijie, Ding, Xia, Chen, Zhe, Huang, Yun, Ding, Wanjing
Natura: Artículo científico
Lingua:en
Pubblicazione: European journal of pharmacology 2025
Accesso online:https://pubmed.ncbi.nlm.nih.gov/40854787/
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1868266162702254080
author Zhan, Shuai
Zhang, Ningjing
Lou, Yijie
Ding, Xia
Chen, Zhe
Huang, Yun
Ding, Wanjing
author_facet Zhan, Shuai
Zhang, Ningjing
Lou, Yijie
Ding, Xia
Chen, Zhe
Huang, Yun
Ding, Wanjing
Zhan, Shuai
Zhang, Ningjing
Lou, Yijie
Ding, Xia
Chen, Zhe
Huang, Yun
Ding, Wanjing
collection PubMed - marine biology
contents Corrigendum to "Degradation of NLRP3 by selective ROCK2 inhibitor alleviates acute lung injury" [Eur. J. Pharmacol. 1004 (2025) 178009]. Zhan, Shuai Zhang, Ningjing Lou, Yijie Ding, Xia Chen, Zhe Huang, Yun Ding, Wanjing
format Artículo científico
id pubmed_40854787
institution PubMed
language en
publishDate 2025
publisher European journal of pharmacology
record_format pubmed
spellingShingle Corrigendum to "Degradation of NLRP3 by selective ROCK2 inhibitor alleviates acute lung injury" [Eur. J. Pharmacol. 1004 (2025) 178009].
Zhan, Shuai
Zhang, Ningjing
Lou, Yijie
Ding, Xia
Chen, Zhe
Huang, Yun
Ding, Wanjing
Corrigendum to "Degradation of NLRP3 by selective ROCK2 inhibitor alleviates acute lung injury" [Eur. J. Pharmacol. 1004 (2025) 178009]. Zhan, Shuai Zhang, Ningjing Lou, Yijie Ding, Xia Chen, Zhe Huang, Yun Ding, Wanjing
title Corrigendum to "Degradation of NLRP3 by selective ROCK2 inhibitor alleviates acute lung injury" [Eur. J. Pharmacol. 1004 (2025) 178009].
url https://pubmed.ncbi.nlm.nih.gov/40854787/